A new trading day began on Friday, with Neogenomics Inc (NASDAQ: NEO) stock price up 3.30% from the previous day of trading, before settling in for the closing price of $10.01. NEO’s price has ranged from $4.72 to $19.11 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -14.42%. With a float of $125.28 million, this company’s outstanding shares have now reached $128.89 million.
Neogenomics Inc (NEO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Neogenomics Inc is 3.17%, while institutional ownership is 96.59%. The most recent insider transaction that took place on Oct 16 ’25, was worth 49,032. Before that another transaction happened on Aug 06 ’25, when Company’s Chief Financial Officer bought 20,000 for $5.62, making the entire transaction worth $112,322. This insider now owns 188,332 shares in total.
Neogenomics Inc (NEO) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
Neogenomics Inc (NASDAQ: NEO) Trading Performance Indicators
Here are Neogenomics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.17 in one year’s time.
Technical Analysis of Neogenomics Inc (NEO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.78 million. That was inferior than the volume of 2.4 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.90%.
During the past 100 days, Neogenomics Inc’s (NEO) raw stochastic average was set at 83.99%, which indicates a significant increase from 46.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.63 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.24, while its 200-day Moving Average is $8.67. However, in the short run, Neogenomics Inc’s stock first resistance to watch stands at $10.61. Second resistance stands at $10.89. The third major resistance level sits at $11.34. If the price goes on to break the first support level at $9.89, it is likely to go to the next support level at $9.44. Assuming the price breaks the second support level, the third support level stands at $9.16.
Neogenomics Inc (NASDAQ: NEO) Key Stats
With a market capitalization of 1.34 billion, the company has a total of 129,388K Shares Outstanding. Currently, annual sales are 660,570 K while annual income is -78,730 K. The company’s previous quarter sales were 187,800 K while its latest quarter income was -27,130 K.
